Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions
Clinical trial NCT00835263 · COMPLETED
Trial details
- NCT number
- NCT00835263
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2002-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.